Financing channel feed – Endpoints News

Financing channel feed

Septerna’s $150M infusion will help prove whether it’s got the right pill for hypoparathyroidism

Last year

Apogee and Sagimet’s IPO plans come into view, with targeted raises of $228M and $66M

Last year

WuXi Biologics seeks spinout, HK listing of bioconjugates-focused joint venture

Last year

Jeff Leerink talks about why he's resurrecting Leerink Partners after buying his firm back from bankrupt SVB

Last year

California Alzheimer's startup TrueBinding raises more than $50M, lays off workers twice in June

Last year

FDA lifts partial hold on Curis' PhI/II leukemia study as biotech raises $15M

Last year

DNA synthesis upstart raises $10M to scale operations

Last year

Cancer biotech Intensity Therapeutics looks to pull in $16M+ IPO

Last year

Corrected: Westlake targets $450M for Seidenberg's next life sciences fund

Last year

Touting programs from Novartis, Laekna bags $100M in Hong Kong IPO while Merck-partnered Kelun seeks up to $208M

Last year

Immutep picks up more funds for LAG-3 oncology and autoimmune studies

Last year

K36 Therapeutics raises $70M in Series B to fund multiple myeloma research

Last year

A French startup wants to decentralize cell and gene therapy manufacturing, making it 'the size of a book'

Last year

Life science VC Vertex Ventures HC raises $200M in new fund

Last year

Luminopia scores $16M for virtual reality-based lazy eye treatment

Last year

MoonLake's mid-stage IL-17 data sent shares skyrocketing. Now it plans to sell $250M in stock

Last year

Sagimet Biosciences files again for an IPO after releasing NASH data

Last year

Oncolytic virus startup Calidi secures $25M toward Series B round

Last year

Elucida Oncology nabs more funds for its take on ADCs, sees potential in radiotherapy partnership

Last year

Apogee files to go public, unveiling plans to make a play for Dupixent's turf

Last year

Aeglea BioTherapeutics acquires startup Spyre in bid to go after Merck’s Prometheus, Roivant’s Telavant

Last year

Tourmaline Bio reverse merges into Talaris and raises funds to target thyroid eye disease and pharma rivals

Last year

Tagworks lands $65M for its take on Nobel-winning click chemistry in bid to expand ADC, radiopharma potential

Last year

Portal Innovations to call Houston its third home, with CAR-T startup March Biosciences already in the portfolio

Last year

First page Previous page 30 31 323334 35 36 Next page Last page